The American Journal of Managed Care12d
Community, Connection, and Sharing the Science at CROI 2025
Experts share here what they take away from the Conference on Retroviruses and Opportunistic Infections (CROI) each year and ...
The American Journal of Managed Care11d
CROI Offered Breaking Research, Important Discussions in HIV
The Conference on Retroviruses and Opportunistic Infections 2025 (CROI) featured multiple sessions that focused on breaking research and treatments.
AllAfrica.com10d
Africa: A Jab That Could Protect Against HIV for a Year At a Time, and Other Highlights From Major Conference
Spotlight reports on this and some of the other exciting research on long-acting anti-HIV medicines presented at the ...
Aidsmap26d
aidsmap returns with reporting from the Conference on Retroviruses and Opportunistic Infections (CROI)
News reporting will resume with coverage of the Conference on Retroviruses and Opportunistic Infections (CROI), being held in San Francisco from 9 to 12 March. Our reporting team from CROI are Keith ...
News2413d
Fund research not Tesla trucks: The HIV casualties of Trump's war on science
This year there were empty seats at the prestigious Conference on Retroviruses and Opportunistic Infections, Croi, in San Francisco, where groundbreaking HIV research gets presented. Missing from the ...
Healio15d
Long-acting treatment benefits postpartum women with HIV and their babies
Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant ...
Healio10d
Increasing HPV vaccine coverage may decrease cancers among people with HIV
Increasing HPV vaccination rates could help decrease the number of cancer cases “attributable to HIV,” according to data from ...
Medscape9d
Twice Daily TB Therapies Show Similar Neuropsychiatric Outcomes in Patients with HIV
Previous research has suggested an increased risk for neuropsychiatric symptoms in people living with HIV who are being ...
Bay Area Reporter17d
At CROI conference, HIV activists sound alarm on Trump policies
AIDS advocates are fearful that budget cuts being pushed by Republicans will gut essential health care services in the United ...
HealthDay on MSN8d
Ensitrelvir Effectively Prevents Spread of COVID-19 in Households
For household contacts of individuals with COVID-19, taking ensitrelvir within 72 hours of symptoms is effective at ...
Gilead Presents New HIV Treatment and Cure Research Data at CROI 2025, Including an Investigational Long-Acting, Twice-Yearly Therapy Option
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment portfolio and pipeline at the Conference ...
Gilead Presents New HIV Treatment And Cure Research Data
Gilead Sciences, Inc. (NASDAQ:GILD) presented data from its HIV treatment portfolio and pipeline at the Conference on Retroviruses and Opportunistic Infections (CROI 2025). ALLIANCE is an ongoing ...